Additional file 2: of The CXCR4 antagonist plerixafor enhances the effect of rituximab in diffuse large B-cell lymphoma cell lines

Linn Reinholdt (Creator)
Maria Bach Laursen (Creator)
Alexander Schmitz (Creator)
Julie Støve Bødker (Creator)
Lasse Hjort Kyneb Jakobsen (Creator)
Martin Bøgsted (Creator)
Hans Erik Johnsen (Creator)
Karen Dybkær (Contributor)

Dataset

Description

Data used to generate Figure 1. (XLSX 26 kb)

Date made available	14 Jun 2016
Publisher	Figshare

DOI
10.6084/m9.figshare.c.3618047_d5.v1

Access Dataset

CC BY + CC0

1 Journal article

The CXCR4 antagonist plerixafor enhances the effect of rituximab in diffuse large B-cell lymphoma cell lines
Reinholdt, L., Laursen, M. B., Schmitz, A., Bødker, J. S., Jakobsen, L. H., Bøgsted, M., Johnsen, H. E. & Dybkær, K., 2016, In: Biomarker Research. 4, 12 p., 12.
Research output: Contribution to journal › Journal article › Research › peer-review

Open Access
30 Citations (Scopus)

Cite this

Reinholdt, L. (Creator), Laursen, M. B. (Creator), Schmitz, A. (Creator), Bødker, J. S. (Creator), Jakobsen, L. H. (Creator), Bøgsted, M. (Creator), Johnsen, H. E. (Creator), Dybkaer, K. (Contributor) (14 Jun 2016). Additional file 2: of The CXCR4 antagonist plerixafor enhances the effect of rituximab in diffuse large B-cell lymphoma cell lines. Figshare. 10.6084/m9.figshare.c.3618047_d5.v1

Additional file 2: of The CXCR4 antagonist plerixafor enhances the effect of rituximab in diffuse large B-cell lymphoma cell lines

Description

DOI

Access Dataset

Research output

The CXCR4 antagonist plerixafor enhances the effect of rituximab in diffuse large B-cell lymphoma cell lines

Cite this